Rockville, Maryland — September 30, 2026 — The home uroflowmetry devices market is valued at USD 155.0 million in 2026 and is projected to reach USD 420.0 million by 2036, expanding at a 10.5% CAGR during the forecast period. The market is moving beyond hospital-centered urinary flow testing as patients, clinicians, and telehealth providers increasingly seek repeated measurements in home settings. Portable diagnostic systems can capture urine flow rate, voided volume, and voiding patterns while supporting remote assessment of lower urinary tract function.

Get detailed market forecasts, competitive benchmarking, and pricing trends:

Demand is being strengthened by the growing adoption of remote patient monitoring and the need for longitudinal evaluation of urinary flow characteristics. Benign prostatic hyperplasia, urinary dysfunction, and urinary incontinence often require repeated assessment, creating demand for diagnostic solutions that reduce dependence on frequent clinical visits. Digital health platforms are also enabling transmission of uroflowmetry data to healthcare providers, allowing recorded measurements to support treatment monitoring and clinical decision-making. Increasing use of connected diagnostic technologies is therefore becoming an important element of home-based urology workflows.

Home care patients represent the leading end-user segment, accounting for 48% of the market in 2026. Their lead reflects greater preference for remote monitoring of urinary flow parameters and the convenience of collecting diagnostic data outside clinical environments. Portable uroflowmetry devices hold 46% of the product type segment, supported by compact designs that allow repeated measurements at home and electronic sensors capable of recording flow-rate curves. Connected smart devices and app-enabled kits further support data transfer through telehealth platforms.

Country-level growth shows strong expansion across both emerging and established digital healthcare markets. China is projected to record the highest CAGR at 11.9% through 2036, supported by broader adoption of home-based diagnostic monitoring within urology patient management programs and digital healthcare integration. India follows at 11.5%, with remote urinary flow measurement gaining ground across outpatient care environments as digital health infrastructure expands. The United Kingdom is expected to grow at 11.2%, reflecting continued integration of home diagnostic monitoring into telehealth-enabled patient evaluation workflows. Germany is forecast to advance at 10.9%, supported by digital urology monitoring and connected home diagnostic utilization. The United States records a 10.5% CAGR, with growth linked to an established digital health ecosystem and replacement demand in home diagnostic device supply chains.

Competitive activity centers on manufacturers combining measurement accuracy, ease of use, reliable data recording, and telehealth integration. Key companies profiled in the report include Laborie Medical Technologies Corp., MMS Medical Measurement Systems B.V., MEDICA S.p.A., and Andromeda Medizinische Systeme GmbH. Verathon Inc., SRS Medical Systems Inc., Albyn Medical Ltd., Urovalve Ltd., and The Prometheus Group are also covered in the competitive landscape. Suppliers with established urodynamic expertise and distribution relationships are positioned within procurement evaluations that consider interoperability, calibration stability, compliance, and service reliability.

Shambhu Nath Jha, Principal Consultant at Fact.MR, notes that connected diagnostic monitoring platforms are gaining clinical relevance for remote evaluation of urinary flow patterns across digital urology care environments. The report also highlights opportunities to improve device accuracy, strengthen telehealth integration, expand connected monitoring capabilities, enhance software analytics, and improve usability for long-term home monitoring. Regulatory requirements, including FDA digital health frameworks and EU MDR requirements, remain relevant to product development because clinical accuracy verification can influence timelines. Reimbursement variability and interoperability with clinical information systems are additional considerations for suppliers and healthcare providers.

Post-surgical monitoring, neurogenic bladder monitoring, and pediatric urology assessment are among the applications included in the market scope. Wearable flow sensors and app-enabled diagnostic kits add further product pathways as suppliers develop alternatives to conventional clinic-based measurement. AI-based curve recognition may also improve identification of abnormal voiding patterns and support diagnostic efficiency in tele-urology workflows. These developments reinforce the importance of connected data, patient-friendly interfaces, and accurate flow measurement as the market evolves across home healthcare environments. Providers are evaluating EHR integration to improve continuity of home monitoring workflows.

Unlock 360° insights for strategic decision making and investment planning:

The transition toward repeated, real-world urinary flow measurement creates opportunities for device manufacturers, telehealth providers, urology clinics, and digital health stakeholders. As home diagnostics become more connected, suppliers can focus on reliable measurement, practical patient use, data interoperability, and clinical reporting. The full Fact.MR report provides detailed market forecasts, segment analysis, country-level growth assessments, competitive benchmarking, and technology trends through 2036.

Explore More Related Studies Published by Fact.MR Research

Plasmapheresis Market

Chromatography Syringes Market

Movement Disorder Market

About Fact.MR

Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.

 - Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com